The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy
Drug Resistance Updates · 2026-03 · 85 · 101355
DOI: 10.1016/j.drup.2026.101355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-03. Verfasst von Muhammad Tufail und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Hospital of Shantou University Medical College, Shantou, China. Electronic address: mtufail0276@gmail.com. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Signal Transduction, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 991 Literaturangaben. Gefördert von: Shantou University Medical College, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Hospital of Shantou University Medical College, Shantou, China. Electronic address: mtufail0276@gmail.com.
- Scientific Research Center, First School of Clinical Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China. Electronic address: gkx13265040169@126.com.
- Applied and Functional Genomics Lab, Centre of Excellence in Molecular Biology, University of the Punjab, 87-West canal Road Thokar Niaz Baig, Lahore, India. Electronic address: bijaz@cemb.edu.pk.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York 11439, USA. Electronic address: harsh.patel17@my.stjohns.edu.
- Department of Oncology-Pathology, Karolinska Institutet, BioClinicum, Karolinska University Hospital, Solna, Sweden. Electronic address: weng-onn.lui@ki.se.
- Department of Oncology, Affiliated Lianyungang Clinical College of Nantong University, Lianyungang 222006, China. Electronic address: wangxiumei75@163.com.
Förderung
- Shantou University Medical College
- National Natural Science Foundation of China
Zitieren
APA
Tufail, M., Gong, K., Ijaz, B., Patel, H., Lui, W. O., Wang, X., & Li, J. (2026). The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy. Drug Resistance Updates, 85, 101355. https://doi.org/10.1016/j.drup.2026.101355
Vancouver
Tufail M, Gong K, Ijaz B, Patel H, Lui WO, Wang X, et al. The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy. Drug Resistance Updates. 2026;85:101355. doi:10.1016/j.drup.2026.101355
BibTeX
@article{Tufail2026,
author = {Tufail, Muhammad and Gong, Kunxiang and Ijaz, Bushra and Patel, Harsh and Lui, Weng-Onn and Wang, Xiumei and Li, Jie},
title = {The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy},
journal = {Drug Resistance Updates},
year = {2026},
volume = {85},
pages = {101355},
doi = {10.1016/j.drup.2026.101355}
}
EUVIMED